These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 622176)

  • 21. Comparison of the hydroxylation of benzo(a)pyrene with the metabolism of vinyl chloride, N-nitrosomorpholine, and N-nitroso-N'-methylpiperazine to mutagens by human and rat liver microsomal fractions.
    Sabadie N; Malaveille C; Camus AM; Bartsch H
    Cancer Res; 1980 Jan; 40(1):119-26. PubMed ID: 7349891
    [No Abstract]   [Full Text] [Related]  

  • 22. Development of short-term mutagenicity test systems in vitro: metabolic activation of indirectly acting mutagens by three immortal rat hepatocyte lines.
    Kulka U; Paul D; Bauchinger M
    Mutagenesis; 1993 May; 8(3):193-7. PubMed ID: 8332081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic activation of 3-methylcholanthrene and its metabolites to products mutagenic to bacterial and mammalian cells.
    Wood AW; Chang RL; Levin W; Thomas PE; Ryan D; Stoming TA; Thakker DR; Jerina DM; Conney AH
    Cancer Res; 1978 Oct; 38(10):3398-404. PubMed ID: 356964
    [No Abstract]   [Full Text] [Related]  

  • 24. Metabolism of 1-nitrobenzo[a]pyrene by rat liver microsomes to potent mutagenic metabolites.
    Chou MW; Heflich RH; Fu PP
    Carcinogenesis; 1986 Nov; 7(11):1837-44. PubMed ID: 3769131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lung and liver cell-mediated mutagenesis systems: specificities in the activation of chemical carcinogens.
    Langenbach R; Nesnow S; Tompa A; Gingell R; Kuszynski C
    Carcinogenesis; 1981; 2(9):851-8. PubMed ID: 6271413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of inhibition by ascorbate of microbial mutagenesis induced by N-nitroso compounds.
    Guttenplan JB
    Cancer Res; 1978 Jul; 38(7):2018-22. PubMed ID: 350382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of dimethylnitrosamine metabolism and activation in rats.
    Godoy HM; Diaz Gomez MI; Castro JA
    J Natl Cancer Inst; 1978 Nov; 61(5):1285-9. PubMed ID: 30846
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of primary hepatocytes and S9 metabolic activation systems for the C3H-10T 1/2 cell transformation assay.
    Tu AS; Breen PA; Sivak A
    Carcinogenesis; 1984 Nov; 5(11):1431-6. PubMed ID: 6488466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural requirements for the metabolic activation of benzo[a]pyrene to mutagenic products: effects of modifications in the 4,5-, 7,8-, and 9,10-positions.
    Wood AW; Levin W; Lu AY; Ryan D; West SB; Yagi H; Mah HD; Jerina DM; Conney AH
    Mol Pharmacol; 1977 Nov; 13(6):1116-25. PubMed ID: 339055
    [No Abstract]   [Full Text] [Related]  

  • 30. Human lymphocytes as target cells in a metabolizing test system in vitro for detecting potential mutagens.
    Bimboes D; Greim H
    Mutat Res; 1976 Apr; 35(1):155-60. PubMed ID: 1272268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic activation of dibenzo(a,h)anthracene and its dihydrodiols to bacterial mutagens.
    Wood AW; Levin W; Thomas PE; Ryan D; Karle JM; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1978 Jul; 38(7):1967-73. PubMed ID: 350381
    [No Abstract]   [Full Text] [Related]  

  • 32. Benzo[a]pyrene carcinogenesis: a biochemical selection mechanism.
    Selkirk JK
    J Toxicol Environ Health; 1977 Jul; 2(6):1245-58. PubMed ID: 328915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutagenicity of dimethylnitrosamine to mammalian cells as determined by the use of mouse liver microsomes.
    Umeda M; Saito M
    Mutat Res; 1975 Nov; 30(2):249-54. PubMed ID: 1207708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunochemical study on the role of different types of microsomal cytochrome P-450 in mutagenesis by chemical carcinogens.
    Kawajiri K; Yonekawa H; Harada N; Noshiro M; Omura T; Tagashira Y
    Cancer Res; 1980 May; 40(5):1652-7. PubMed ID: 6768451
    [No Abstract]   [Full Text] [Related]  

  • 35. [Modifying effect of antioxidants on the biotransformation of dialkyl-N-nitrosamines in microsomes. A spin trap method].
    Pakhomov VIu; Shuliakovskaia TS; Artemova LG; Saprin AN
    Dokl Akad Nauk SSSR; 1986; 286(5):1264-8. PubMed ID: 3004873
    [No Abstract]   [Full Text] [Related]  

  • 36. Microsomal metabolism of 1-nitrobenzo[e]pyrene to a highly mutagenic K-region dihydrodiol.
    Fu PP; Heflich RH; Von Tungeln LS; Miranda HZ; Evans FE
    Carcinogenesis; 1988 Jun; 9(6):951-8. PubMed ID: 3286032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulatory effects of testosterone and 17 beta-oestradiol on the metabolism of dimethylnitrosamine by renal and hepatic microsomal enzymes from BALB/c mice.
    Ampy FR; Asseffa A
    Cytobios; 1988; 55(221):87-94. PubMed ID: 3229148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo effects of N-acetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic compounds.
    De Flora S; Bennicelli C; Camoirano A; Serra D; Romano M; Rossi GA; Morelli A; De Flora A
    Carcinogenesis; 1985 Dec; 6(12):1735-45. PubMed ID: 3905042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocyte activation of indirect mutagens during the first days in primary culture.
    George-Madle E; Kasper P; Madle S
    Mutagenesis; 1987 Sep; 2(5):337-40. PubMed ID: 3125405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism of the mutagenic environmental pollutant, 6-nitrobenzo[a]pyrene: metabolic activation via ring oxidation.
    Fu PP; Chou MW; Yang SK; Beland FA; Kadlubar FF; Casciano DA; Heflich RH; Evans FE
    Biochem Biophys Res Commun; 1982 Apr; 105(3):1037-43. PubMed ID: 7046751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.